Stryker Corporation $SYK Shares Bought by Stratos Wealth Partners LTD.

Stratos Wealth Partners LTD. increased its stake in Stryker Corporation (NYSE:SYK) by 9.2% in the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 19,001 shares of the medical technology company’s stock after buying an additional 1,607 shares during the quarter. Stratos Wealth Partners LTD.’s holdings in Stryker were worth $7,024,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Mid American Wealth Advisory Group Inc. purchased a new stake in shares of Stryker during the second quarter valued at approximately $26,000. Clayton Financial Group LLC acquired a new stake in Stryker during the 3rd quarter valued at $26,000. Elevation Point Wealth Partners LLC purchased a new stake in Stryker during the 2nd quarter worth $28,000. Kilter Group LLC acquired a new position in Stryker in the 2nd quarter worth $29,000. Finally, Howard Hughes Medical Institute purchased a new position in Stryker in the 2nd quarter valued at about $29,000. 77.09% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of brokerages recently commented on SYK. Robert W. Baird set a $437.00 price target on Stryker in a report on Friday, January 30th. Evercore set a $390.00 price target on shares of Stryker in a research note on Monday, January 5th. BTIG Research increased their price objective on shares of Stryker from $410.00 to $412.00 and gave the company a “buy” rating in a research note on Friday, January 30th. The Goldman Sachs Group set a $399.00 target price on shares of Stryker in a research note on Friday, January 9th. Finally, Citigroup reiterated a “market outperform” rating on shares of Stryker in a research note on Friday, January 30th. Twelve equities research analysts have rated the stock with a Buy rating and five have given a Hold rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $426.94.

Insider Buying and Selling at Stryker

In other Stryker news, CAO William E. Berry, Jr. sold 1,953 shares of the company’s stock in a transaction dated Friday, November 14th. The shares were sold at an average price of $365.49, for a total value of $713,801.97. Following the completion of the transaction, the chief accounting officer owned 2,833 shares in the company, valued at approximately $1,035,433.17. This represents a 40.81% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CFO Preston Wendell Wells sold 165 shares of Stryker stock in a transaction that occurred on Thursday, November 20th. The shares were sold at an average price of $365.88, for a total value of $60,370.20. Following the sale, the chief financial officer directly owned 6,694 shares in the company, valued at approximately $2,449,200.72. This trade represents a 2.41% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 252,118 shares of company stock valued at $91,504,172 in the last ninety days. Company insiders own 5.90% of the company’s stock.

Stryker Stock Up 0.7%

Shares of Stryker stock opened at $363.76 on Thursday. The stock has a market capitalization of $139.11 billion, a price-to-earnings ratio of 43.30, a PEG ratio of 2.11 and a beta of 0.87. Stryker Corporation has a twelve month low of $329.16 and a twelve month high of $404.87. The company has a current ratio of 1.89, a quick ratio of 1.21 and a debt-to-equity ratio of 0.66. The business’s 50 day simple moving average is $357.92 and its 200-day simple moving average is $369.84.

Stryker (NYSE:SYK) last issued its quarterly earnings data on Thursday, January 29th. The medical technology company reported $4.47 EPS for the quarter, topping analysts’ consensus estimates of $4.40 by $0.07. Stryker had a return on equity of 24.41% and a net margin of 12.92%.The firm had revenue of $7.17 billion during the quarter, compared to the consensus estimate of $7.12 billion. During the same period in the prior year, the business earned $4.01 EPS. The firm’s revenue was up 11.4% on a year-over-year basis. Equities research analysts forecast that Stryker Corporation will post 13.47 earnings per share for the current year.

Stryker Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, April 30th. Investors of record on Tuesday, March 31st will be given a $0.88 dividend. The ex-dividend date is Tuesday, March 31st. This represents a $3.52 annualized dividend and a yield of 1.0%. Stryker’s dividend payout ratio (DPR) is currently 41.90%.

About Stryker

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.